淋巴结与胰腺神经内分泌肿瘤的存活率。

Geoffrey W Krampitz, Jeffrey A Norton, George A Poultsides, Brendan C Visser, Lixian Sun, Robert T Jensen
{"title":"淋巴结与胰腺神经内分泌肿瘤的存活率。","authors":"Geoffrey W Krampitz, Jeffrey A Norton, George A Poultsides, Brendan C Visser, Lixian Sun, Robert T Jensen","doi":"10.1001/archsurg.2012.1261","DOIUrl":null,"url":null,"abstract":"<p><strong>Hypothesis: </strong>Lymph node metastases decrease survival in patients with pancreatic neuroendocrine tumors (pNETs).</p><p><strong>Design: </strong>Prospective database searches.</p><p><strong>Setting: </strong>National Institutes of Health (NIH) and Stanford University Hospital (SUH).</p><p><strong>Patients: </strong>A total of 326 patients underwent surgical exploration for pNETs at the NIH (n = 216) and SUH (n = 110).</p><p><strong>Main outcome measures: </strong>Overall survival, disease-related survival, and time to development of liver metastases.</p><p><strong>Results: </strong>Forty patients (12.3%) underwent enucleation and 305 (93.6%) underwent resection. Of the patients who underwent resection, 117 (35.9%) had partial pancreatectomy and 30 (9.2%) had a Whipple procedure. Forty-one patients also had liver resections, 21 had wedge resections, and 20 had lobectomies. Mean follow-up was 8.1 years (range, 0.3-28.6 years). The 10-year overall survival for patients with no metastases or lymph node metastases only was similar at 80%. As expected, patients with liver metastases had a significantly decreased 10-year survival of 30% (P < .001). The time to development of liver metastases was significantly reduced for patients with lymph node metastases alone compared with those with none (P < .001). For the NIH cohort with longer follow-up, disease-related survival was significantly different for those patients with no metastases, lymph node metastases alone, and liver metastases (P < .001). Extent of lymph node involvement in this subgroup showed that disease-related survival decreased as a function of the number of lymph nodes involved (P = .004).</p><p><strong>Conclusions: </strong>As expected, liver metastases decrease survival of patients with pNETs. Patients with lymph node metastases alone have a shorter time to the development of liver metastases that is dependent on the number of lymph nodes involved. With sufficient long-term follow-up, lymph node metastases decrease disease-related survival. Careful evaluation of number and extent of lymph node involvement is warranted in all surgical procedures for pNETs.</p>","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"820-7"},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448121/pdf/nihms372428.pdf","citationCount":"0","resultStr":"{\"title\":\"Lymph nodes and survival in pancreatic neuroendocrine tumors.\",\"authors\":\"Geoffrey W Krampitz, Jeffrey A Norton, George A Poultsides, Brendan C Visser, Lixian Sun, Robert T Jensen\",\"doi\":\"10.1001/archsurg.2012.1261\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Hypothesis: </strong>Lymph node metastases decrease survival in patients with pancreatic neuroendocrine tumors (pNETs).</p><p><strong>Design: </strong>Prospective database searches.</p><p><strong>Setting: </strong>National Institutes of Health (NIH) and Stanford University Hospital (SUH).</p><p><strong>Patients: </strong>A total of 326 patients underwent surgical exploration for pNETs at the NIH (n = 216) and SUH (n = 110).</p><p><strong>Main outcome measures: </strong>Overall survival, disease-related survival, and time to development of liver metastases.</p><p><strong>Results: </strong>Forty patients (12.3%) underwent enucleation and 305 (93.6%) underwent resection. Of the patients who underwent resection, 117 (35.9%) had partial pancreatectomy and 30 (9.2%) had a Whipple procedure. Forty-one patients also had liver resections, 21 had wedge resections, and 20 had lobectomies. Mean follow-up was 8.1 years (range, 0.3-28.6 years). The 10-year overall survival for patients with no metastases or lymph node metastases only was similar at 80%. As expected, patients with liver metastases had a significantly decreased 10-year survival of 30% (P < .001). The time to development of liver metastases was significantly reduced for patients with lymph node metastases alone compared with those with none (P < .001). For the NIH cohort with longer follow-up, disease-related survival was significantly different for those patients with no metastases, lymph node metastases alone, and liver metastases (P < .001). Extent of lymph node involvement in this subgroup showed that disease-related survival decreased as a function of the number of lymph nodes involved (P = .004).</p><p><strong>Conclusions: </strong>As expected, liver metastases decrease survival of patients with pNETs. Patients with lymph node metastases alone have a shorter time to the development of liver metastases that is dependent on the number of lymph nodes involved. With sufficient long-term follow-up, lymph node metastases decrease disease-related survival. Careful evaluation of number and extent of lymph node involvement is warranted in all surgical procedures for pNETs.</p>\",\"PeriodicalId\":8298,\"journal\":{\"name\":\"Archives of Surgery\",\"volume\":\"147 9\",\"pages\":\"820-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448121/pdf/nihms372428.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/archsurg.2012.1261\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/archsurg.2012.1261","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

假设:淋巴结转移会降低胰腺神经内分泌肿瘤(pNET)患者的生存率:淋巴结转移会降低胰腺神经内分泌肿瘤(pNETs)患者的生存率:前瞻性数据库搜索:美国国立卫生研究院(NIH)和斯坦福大学医院(SUH):美国国立卫生研究院(NIH)(n = 216)和斯坦福大学医院(SUH)(n = 110)共有326名患者接受了pNET手术探查:主要结果指标:总生存率、疾病相关生存率和发生肝转移的时间:40名患者(12.3%)接受了去核手术,305名患者(93.6%)接受了切除手术。在接受切除术的患者中,117人(35.9%)接受了胰腺部分切除术,30人(9.2%)接受了Whipple手术。41名患者还进行了肝脏切除术,21名患者进行了楔形切除术,20名患者进行了肝叶切除术。平均随访时间为 8.1 年(0.3-28.6 年)。无转移或仅有淋巴结转移的患者的10年总生存率相似,均为80%。不出所料,肝转移患者的 10 年生存率明显降低,仅为 30%(P < .001)。与没有淋巴结转移的患者相比,仅有淋巴结转移的患者发生肝转移的时间明显缩短(P < .001)。在随访时间较长的NIH队列中,无转移、仅有淋巴结转移和肝转移患者的疾病相关生存率有明显差异(P < .001)。该亚组的淋巴结受累程度显示,疾病相关生存率随着受累淋巴结数量的增加而降低(P = .004):正如所料,肝转移会降低 pNET 患者的生存率。仅有淋巴结转移的患者发生肝转移的时间较短,这取决于受累淋巴结的数量。在充分的长期随访中,淋巴结转移会降低疾病相关生存率。在所有治疗 pNET 的外科手术中,都应仔细评估淋巴结受累的数量和范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Lymph nodes and survival in pancreatic neuroendocrine tumors.

Hypothesis: Lymph node metastases decrease survival in patients with pancreatic neuroendocrine tumors (pNETs).

Design: Prospective database searches.

Setting: National Institutes of Health (NIH) and Stanford University Hospital (SUH).

Patients: A total of 326 patients underwent surgical exploration for pNETs at the NIH (n = 216) and SUH (n = 110).

Main outcome measures: Overall survival, disease-related survival, and time to development of liver metastases.

Results: Forty patients (12.3%) underwent enucleation and 305 (93.6%) underwent resection. Of the patients who underwent resection, 117 (35.9%) had partial pancreatectomy and 30 (9.2%) had a Whipple procedure. Forty-one patients also had liver resections, 21 had wedge resections, and 20 had lobectomies. Mean follow-up was 8.1 years (range, 0.3-28.6 years). The 10-year overall survival for patients with no metastases or lymph node metastases only was similar at 80%. As expected, patients with liver metastases had a significantly decreased 10-year survival of 30% (P < .001). The time to development of liver metastases was significantly reduced for patients with lymph node metastases alone compared with those with none (P < .001). For the NIH cohort with longer follow-up, disease-related survival was significantly different for those patients with no metastases, lymph node metastases alone, and liver metastases (P < .001). Extent of lymph node involvement in this subgroup showed that disease-related survival decreased as a function of the number of lymph nodes involved (P = .004).

Conclusions: As expected, liver metastases decrease survival of patients with pNETs. Patients with lymph node metastases alone have a shorter time to the development of liver metastases that is dependent on the number of lymph nodes involved. With sufficient long-term follow-up, lymph node metastases decrease disease-related survival. Careful evaluation of number and extent of lymph node involvement is warranted in all surgical procedures for pNETs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Surgery
Archives of Surgery 医学-外科
自引率
0.00%
发文量
0
审稿时长
4-8 weeks
期刊最新文献
Synchronous Breast and Thyroid Cancer: Correlation Between two Pathologies and Management Challenges Vascularized Transposition of the Ulnar Nerve in Entrapment Syndrome at the Elbow Pseudohermaphroditism. Brothers. Preoperative biopsy evaluation of chemotherapy-associated liver injuries: looking for a needle in a haystack? Comment on "prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injury".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1